Newsroom

Sorted by: Latest

-

PipeChain acquiert la société néerlandaise de progiciels de chaîne d’approvisionnement Quyntess, élargissant ainsi sa présence mondiale et renforçant ses capacités de numérisation de bout en bout

STOCKHOLM--(BUSINESS WIRE)--PipeChain, fournisseur mondial de progiciels de planification et d’exécution collaboratives basés sur le cloud et destinés aux grandes multinationales, ainsi que de solutions de réseaux multi-entreprises pour les secteurs de l’automobile et de la vente au détail, a annoncé aujourd’hui l’acquisition de la société néerlandaise de progiciels de chaîne d’approvisionnement Quyntess Holding B.V. (« Quyntess », https://www.quyntess.com/), qui dispose d’opérations bien établ...
-

Alliant Insurance Services Hires Joseph Ehrlich as Executive Vice President in Mergers & Acquisitions Vertical

IRVINE, Calif.--(BUSINESS WIRE)--Joseph Ehrlich has joined Alliant Insurance Services as Executive Vice President within its Mergers & Acquisitions (M&A) vertical....
-

Ameresco Completes Wastewater Infrastructure Rehabilitation Project for the City of Mesquite

FRAMINGHAM, Mass. & MESQUITE, Texas--(BUSINESS WIRE)--Ameresco completes first phase manhole rehabilitation in Mesquite, TX, improving wastewater reliability, and enhancing community safety....
-

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstracts, as well as one oral presentation in partnership with Pfizer, showcasing advances in methylation-based tumor classification and liquid biopsy technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois taking place May 29 – June 2, 2026. Key data that will be prese...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 27.05.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,313,656.86 26.272  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 27.05.2026 FGBL.LN IE00BYTH6121 1,020,847.00 USD 98,594,657.79 96.581  ...
-

Baker Global Asset Management, Inc. Signs Non-Binding Letter of Intent with QLUBO Nordic AB for Potential Strategic European Expansion

PENSACOLA, Fla.--(BUSINESS WIRE)--Baker Global Asset Management, Inc. (OTCQB: BAKR) (“Baker Global” or the “Company”), the parent company of Benjamin Securities, Inc. (est. 1977), a FINRA-licensed broker-dealer and SEC-registered investment advisor, today announced that it has entered into a non-binding Letter of Intent (“LOI”) with QLUBO Nordic AB (“QLUBO”), a Swedish company, to explore a potential strategic investment and partnership focused on the Swedish and broader European Union investme...
-

Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Andrew Miller, Ph.D. to its Board of Directors, effective May 27, 2026. “We are thrilled to welcome Andrew to Alto’s Board at a transformative time for the Company,” said Amit Etkin, M.D., Ph.D., Founder and Chief Executive Officer of Alto Neuros...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 27.05.2026 FEUZ IE00B8X9NY41 1,853,194.00 EUR 120,209,865.76 64.866  ...
-

Syncell Launches High-Precision Proteomics Discovery Service Powered by Microscoop® Mint Platform

LIVERMORE, Calif., & TAIPEI, Taiwan--(BUSINESS WIRE)--Syncell announced the commercial launch of Syncell Discovery Services, a global sample-to-discovery program powered by the Microscoop Mint platform...